Table 1 Clinical characteristics of healthy non-pregnant and pregnant women and pre-eclamptic patients

From: Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia

 

Healthy non-pregnant women (n=52)

Healthy pregnant women (n=58)

Pre-eclamptic patients (n=54)

Age (years)

28 (25–34)

30 (28–32)

29 (26–33)

BMI at blood draw (kg m–2)

20.9 (19.7–23.3)

25.8 (24.2–28.0)a

29.8 (27.4–31.9)a,b

Smokers

12 (23.1%)

0 (0%)a

3 (5.6%)c

Primiparas

NA

35 (60.3%)

33 (61.1%)

Systolic blood pressure at blood draw (mm Hg)

110 (110–120)

110 (105–120)

160 (153–180)a,b

Diastolic blood pressure at blood draw (mm Hg)

80 (70–80)

70 (60–80)a

100 (97–110)a,b

Gestational age at disease onset (weeks)

NA

NA

36 (36–38)

Gestational age at blood draw (weeks)

NA

36 (36–37)

37 (36–39)

Gestational age at delivery (weeks)

NA

39 (38–40)

38 (37–39)b

Fetal birth weight (g)

NA

3450 (3150–3700)

3075 (2450–3450)b

Fetal growth restriction

NA

0 (0%)

9 (16.7%)d

  1. Abbreviations: BMI, body mass index; NA, not applicable.
  2. Data are presented as median (25–75 percentile) for continuous variables and as number (percentage) for categorical variables.
  3. aP<0.001 vs. healthy non-pregnant women.
  4. bP<0.001 pre-eclamptic patients vs. healthy pregnant women.
  5. cP<0.05 vs. healthy non-pregnant women.
  6. dP<0.05 pre-eclamptic patients vs. healthy pregnant women.
Back to article page